- Home
- /
- News
- /
- Pharmacology/ Therapeutics
- /
- June 2012
Pharmacology/ Therapeutics News for June 2012
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds.
26 June, 2012
Researchers studying the genetic roots of the most common malignant childhood brain tumor have discovered missteps in three of the four subtypes of the cancer that involve genes already targeted for drug development. The work was published on the online issue of the scientific journal Nature.
21 June, 2012
The fight against cancer is leading a new movement in gene therapy, as the failure of conventional cancer therapies is fuelling demand for new treatments, according to a new report by healthcare experts GBI Research.
18 June, 2012
A recent placebo-controlled study reveals new evidence of trans-cranial bright light's effect to brain functions when administered through the ear. The new research findings from Finland were published in the World Journal of Neuroscience.
15 June, 2012
Preclinical results published in the Journal of Hormone Molecular Biology and Clinical Investigation Estetrol proven to have an estrogen antagonistic effect on breast tumour tissue.
07 June, 2012
The Government is too focused on encouraging ‘breakthrough drugs’ at the expense of significant gains for patients from incremental innovation in medicines, warned Stephen Whitehead, Chief Executive of the ABPI. Stephen Whitehead warned that this approach threatens the future of pharmaceutical medical research in the UK.
06 June, 2012
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology.
01 June, 2012